AbbVie: Neuralgia trials
The registry lists 10 Neuralgia studies with AbbVie as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 2 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic NeuralgiaTerminatedNCT01678924Phase 2Results posted
- A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic NeuralgiaCompletedNCT01129531Phase 2Results posted
- Safety and Efficacy of AGN201781 in Neuropathic PainTerminatedNCT00533351Phase 2Results posted
- A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral NeuropathyCompletedNCT01589432Phase 2
- A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic PainTerminatedNCT01579279Phase 2
- A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic PainCompletedNCT01345045Phase 2
- Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic PainCompletedNCT00838799Phase 2
- A Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainCompletedNCT00548925Phase 2
- Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainCompletedNCT00507936Phase 2
- A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic NeuralgiaCompletedNCT00168441Phase 2